Increased immune gene expression and immune cell infiltration in high-grade astrocytoma distinguish long-term from short-term survivors.
Increased immune gene expression and immune cell infiltration in high-grade astrocytoma distinguish long-term from short-term survivors.
复制标题
DOI:
10.4049/jimmunol.1103373
复制
发表时间:
2012-08-15
期刊:
影响因子:
--
通讯作者:
Foreman NK
中科院分区:
文献类型:
--
作者:
Donson AM;Birks DK;Schittone SA;Kleinschmidt-DeMasters BK;Sun DY;Hemenway MF;Handler MH;Waziri AE;Wang M;Foreman NK
Survival in the majority of high grade astrocytoma (HGA) patients is very poor, with only a rare population of long-term survivors. A better understanding of the biological factors associated with long-term survival in HGA would aid development of more effective therapy and survival prediction. Factors associated with long-term survival have not been extensively studied using unbiased genome-wide expression analyses. In the present study, gene expression microarray profiles of HGA from long-term survivors were interrogated for discovery of survival-associated biological factors. Ontology analyses revealed that increased expression of immune function-related genes was the predominant biological factor that positively correlated with longer survival. A notable T-cell signature was present within this prognostic immune gene-set. Using immune cell-specific gene classifiers, both T-cell and myeloid linage-associated genes were shown to be enriched in HGA from long versus short-term survivors. Association of immune function and cell-specific genes with survival was confirmed independently in a larger publicly available glioblastoma gene expression microarray dataset. Histology was used to validate the results of microarray analyses in a larger cohort of long-term survivors of HGA. Multivariate analyses demonstrated that increased immune cell infiltration was a significant independent variable contributing to longer survival, as was Karnofsky/Lansky performance score. These data provide evidence of a prognostic anti-tumor adaptive immune response and rationale for future development of immunotherapy in HGA.
登录
查看更多内容
影响因子:
7
作者:
Filen, Jan-Jonas;Filen, Sanna;Lahesmaa, Riitta
通讯作者:
Lahesmaa, Riitta
影响因子:
15.9
作者:
Hussain, S. Farzana;Yang, David;Heimberger, Amy B.
通讯作者:
Heimberger, Amy B.
影响因子:
50.3
作者:
Phillips, HS;Kharbanda, S;Aldape, K
通讯作者:
Aldape, K
影响因子:
11.2
作者:
Fecci, PE;Mitchell, DA;Sampson, JH
通讯作者:
Sampson, JH
影响因子:
4.1
作者:
PALMA, L;DILORENZO, N;GUIDETTI, B
通讯作者:
GUIDETTI, B